Brief: Idorsia Financial Guidance For 2026 Unchanged
April 28 (Reuters) - Idorsia Ltd IDIA.S: Q1 EBIT CHF -26 MILLION Q1 REVENUE CHF 57 MILLION Q1 BASIC EPS CHF -0.18 Q1 EPS CHF -0.18 Q1 NET INCOME CHF -46 MILLION Q1 2026 * QUVIVIQ SALES: CHF 44 MILLION (EXCLUDING SALES TO PARTNERS) FINANCIAL GUIDANCE FOR 2026 UNCHANGED Source text: ID:nGNE4zvQt7 Further company coverage: IDIA.S (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Idorsia
See all newsBrief: Idorsia Enters Senior Secured Term Loan Of Up To CHF 250 Million
Swiss stocks - Factors to watch on May 15
Switzerland's Idorsia posts Q1 loss as high QUVIVIQ sales more than offset by costs, lack of one-time gain
Brief: Idorsia Financial Guidance For 2026 Unchanged
Swiss stocks - Factors to watch on April 28